Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

GBIO Generation Bio Co

Price (delayed)

$0.3874

Market cap

$25.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.08

Enterprise value

$60.5M

Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent ...

Highlights
The gross profit has soared by 146% YoY and by 23% from the previous quarter
GBIO's revenue has surged by 146% year-on-year and by 23% since the previous quarter
The equity has decreased by 44% YoY and by 15% QoQ

Key stats

What are the main financial stats of GBIO
Market
Shares outstanding
67.04M
Market cap
$25.97M
Enterprise value
$60.5M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.35
Price to sales (P/S)
1.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.46
Earnings
Revenue
$24.56M
Gross profit
$24.56M
Operating income
-$81.36M
Net income
-$71.93M
EBIT
-$71.93M
EBITDA
-$67.17M
Free cash flow
-$85.73M
Per share
EPS
-$1.08
EPS diluted
-$1.08
Free cash flow per share
-$1.28
Book value per share
$1.09
Revenue per share
$0.37
TBVPS
$3.01
Balance sheet
Total assets
$201.35M
Total liabilities
$128.02M
Debt
$87.58M
Equity
$73.33M
Working capital
$145.52M
Liquidity
Debt to equity
1.19
Current ratio
8.43
Quick ratio
8.22
Net debt/EBITDA
-0.51
Margins
EBITDA margin
-273.6%
Gross margin
100%
Net margin
-292.9%
Operating margin
-331.3%
Efficiency
Return on assets
-30.4%
Return on equity
-75.8%
Return on invested capital
-28.4%
Return on capital employed
-39.6%
Return on sales
-292.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GBIO stock price

How has the Generation Bio stock price performed over time
Intraday
-2.86%
1 week
5.67%
1 month
-11.13%
1 year
-87.58%
YTD
-63.45%
QTD
-4.35%

Financial performance

How have Generation Bio's revenue and profit performed over time
Revenue
$24.56M
Gross profit
$24.56M
Operating income
-$81.36M
Net income
-$71.93M
Gross margin
100%
Net margin
-292.9%
The gross profit has soared by 146% YoY and by 23% from the previous quarter
GBIO's revenue has surged by 146% year-on-year and by 23% since the previous quarter
Generation Bio's net margin has soared by 83% YoY and by 56% from the previous quarter
GBIO's operating margin has surged by 82% year-on-year and by 54% since the previous quarter

Price vs fundamentals

How does GBIO's price correlate with its fundamentals

Growth

What is Generation Bio's growth rate over time

Valuation

What is Generation Bio stock price valuation
P/E
N/A
P/B
0.35
P/S
1.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.46
Generation Bio's EPS has soared by 58% YoY and by 45% from the previous quarter
The P/B is 83% below the 5-year quarterly average of 2.0 and 68% below the last 4 quarters average of 1.1
The equity has decreased by 44% YoY and by 15% QoQ
GBIO's revenue has surged by 146% year-on-year and by 23% since the previous quarter
GBIO's price to sales (P/S) is 85% lower than its last 4 quarters average of 6.9

Efficiency

How efficient is Generation Bio business performance
Generation Bio's ROS has soared by 83% YoY and by 56% from the previous quarter
Generation Bio's ROIC has increased by 45% YoY and by 40% from the previous quarter
The ROA has grown by 41% from the previous quarter and by 35% YoY
Generation Bio's ROE has increased by 37% from the previous quarter and by 8% YoY

Dividends

What is GBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GBIO.

Financial health

How did Generation Bio financials performed over time
Generation Bio's total assets is 57% higher than its total liabilities
The quick ratio has soared by 53% from the previous quarter and by 5% YoY
The current ratio has soared by 53% since the previous quarter and by 5% year-on-year
Generation Bio's debt is 19% more than its equity
Generation Bio's debt to equity has surged by 63% YoY and by 9% QoQ
The equity has decreased by 44% YoY and by 15% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.